櫻井 宏明

Keyphrases

1. TAK1 100%
2. Phosphorylation 83%
3. NF-B 80%
4. Tumor Necrosis Factor-α 59%
5. Nuclear factor-B 40%
6. Signaling Pathway 30%
7. Transforming Growth Factor-β 28%
8. Mitogen-activated Protein Kinase 27%
9. Epidermal Growth Factor Receptor 26%
10. Metastasis 25%
11. Activator protein-1 (AP-1) 24%
12. Cancer Cells 23%
13. Non-canonical 22%
14. Lymphatic Endothelial Cells 21%
15. TAK1-Binding Proteins 20%
16. Epidermal Growth Factor Receptor Inhibitors (EGFRI) 19%
17. Apoptosis Induction 18%
18. In Cancer 18%
19. Apoptosis 17%
20. Induced Apoptosis 16%
21. TRAIL-induced Apoptosis 16%
22. Extracellular Signal-regulated Kinase 16%
23. Inhibitory Effect 16%
24. Breast Cancer Cells 15%
25. Antitumor Activity 15%
26. Endocytosis 15%
27. Induced Activation 15%
28. Melanoma 15%
29. Kampo Medicine 14%
30. Tumor Cells 13%
31. TAB2 13%
32. Non-small Cell Lung Cancer (NSCLC) 13%
33. DNA Binding 12%
34. Transcription Factor 12%
35. HeLa Cells 12%
36. Plasma Proteins 12%
37. P38 Mitogen-activated Protein Kinase (p38 MAPK) 12%
38. Threonine 11%
39. C-Jun N-terminal Kinase 11%
40. Juzentaihoto 11%
41. Tyrosine Phosphorylation 11%
42. Ubc13 11%
43. Cancer Metastasis 11%
44. Colon 26 11%
45. C-X-C Chemokine Receptor Type 4 (CXCR4) 11%
46. Expression Pattern 11%
47. CX3CR1 11%
48. Curcumin 11%
49. Molecular Mechanism 11%
50. Glomerulonephritis 11%